Best Hospitals for Heart Bypass Surgery in Dubai, UAE

Heart Bypass Surgery (CABG) in India typically costs between $5,000 and $9,000 USD for a standard 2–4 vessel bypass at a JCI or NABH-accredited hospital. This package generally includes the surgical procedure, cardiac anesthesia, 7–10 days of hospital stay (including 1–2 days in the Cardiac ICU), standard post-operative medications, and routine diagnostics. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI or DHA-accredited facility is priced between $14,000 and $22,000 USD — reflecting the higher cost of healthcare infrastructure, premium hospitality standards, and operating costs in the Gulf region. The cost differential of approximately 50–65% in India's favor makes it the leading destination for international patients seeking high-quality cardiac surgery at accessible pricing. Factors that can influence the final cost in either destination include the number of bypass grafts required, the surgical technique employed (conventional on-pump vs. off-pump vs. robotic-assisted), the tier of hospital room selected, the need for additional valve procedures, and the patient's overall risk profile requiring extended ICU care. GAF Healthcare provides written, all-inclusive cost estimates before the patient commits to travel, ensuring complete financial transparency.

For uncomplicated Heart Bypass Surgery (CABG), the minimum recommended in-country stay before international air travel is 4 to 6 weeks from the date of surgery. This timeline accounts for the hospital stay itself (typically 7–10 days), an initial post-discharge recovery period, two mandatory outpatient follow-up appointments (at weeks 2 and 4), and a formal medical fitness-to-fly assessment by the treating cardiac surgeon and cardiologist. The fit-to-fly evaluation considers sternal wound healing, cardiac stability, absence of post-operative complications (such as uncontrolled arrhythmia, pericardial effusion, or wound issues), and the patient's functional capacity. Air travel following open-heart surgery carries specific risks — including reduced cabin pressure reducing oxygen saturation, prolonged immobility increasing deep vein thrombosis (DVT) risk, and the physiological stress of travel — which is why clearance from the surgical team is non-negotiable before flying. For high-risk patients, patients with complications, or those who underwent concomitant valve surgery, the fit-to-fly window may be extended to 6–8 weeks. GAF Healthcare's coordinators work closely with the treating team to plan the patient's return journey, including guidance on seating class (business class or lie-flat recommended for long-haul flights), in-flight medication schedules, compression stocking use, and hydration protocols.

Heart Bypass Surgery performed at high-volume, accredited cardiac centers in India and the UAE carries a procedural success rate of 95–98%, with a 30-day operative mortality rate of approximately 1–2% for elective procedures in low-to-moderate risk patients. These outcomes are consistent with — and in many cases equivalent to — results published by leading cardiac surgery programs in the United States and Europe, such as the Cleveland Clinic and Johns Hopkins. Long-term outcomes are equally favorable: over 90% of patients experience significant or complete relief of angina symptoms, and 5-year survival rates following CABG for multi-vessel coronary artery disease exceed 85–90% in most patient cohorts. Graft patency is the key determinant of long-term success: Left Internal Mammary Artery (LIMA) grafts demonstrate >90% patency at 10 years, while saphenous vein grafts have a 10-year patency of 50–60% — reinforcing the importance of total arterial revascularization strategies and rigorous secondary prevention. Factors that most significantly influence individual outcomes include the patient's pre-operative left ventricular ejection fraction (LVEF), the number and complexity of coronary vessels affected, the presence of diabetes mellitus, renal function, age, and frailty score. Post-operative compliance with antiplatelet therapy, high-intensity statin therapy, blood pressure and blood sugar control, cardiac rehabilitation participation, smoking cessation, and a structured exercise program are the most powerful predictors of excellent long-term outcomes. GAF Healthcare's partner hospitals use validated risk-scoring tools including EuroSCORE II and the STS Predicted Risk of Mortality (PROM) calculator to individualize risk counseling for every patient before surgery.